Controlled Release of LHRH Agonist, Leuprolide Acetate, from Microcapsules: Serum Drug Level Profiles and Pharmacological Effects in Animals
- 1 July 1989
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 41 (7), 439-444
- https://doi.org/10.1111/j.2042-7158.1989.tb06497.x
Abstract
The pharmacokinetic behaviour of leuprolide acetate from a controlled release parenteral dosage form has been studied in rats and dogs. The release of the drug in rats after a single subcutaneous injection exhibited pseudo-zero-order kinetics for one month in doses ranging from 0·0135 to 1·35 mg/rat; the release rate at a dose of 1·35 mg/rat was 2·8% of dose/day; after intramuscular injection the response was similar. In rats, the serum leuprolide acetate levels increased sharply immediately after injection by either route as a consequence of the initial release of the drug; subsequently, the levels attained a plateau for two weeks. The serum level profiles in dogs showed essentially the same pattern as those in rats. When the dosage form was injected into rats, the serum testosterone level (a pharmacological index) sharply peaked, abruptly decreased to below the normal level, and then was sustained at a suppressed level for over six weeks at a dose of 1·35 mg/rat (equivalent to 3 mg kg−1) and higher, while the serum testosterone level after an injection of 0·0135 and 0·135 mg/rat was not sufficiently suppressed. The profiles in dogs showed essentially the same pattern as those in rats. With multiple administrations (once every 4 weeks), serum testosterone levels in dogs did not show any sharp rise after the second and third injections. Changes in rat reproductive organ weights agreed well with the serum testosterone profile in the suppression. The results demonstrate that this dosage form releases the drug at a constant rate for one month and has a long-acting potency.Keywords
This publication has 7 references indexed in Scilit:
- Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: Influence of molecular weight and copolymer ratio of polymer.CHEMICAL & PHARMACEUTICAL BULLETIN, 1988
- Leuprolide: A Gonadotropin-Releasing Hormone Analog for the Palliative Treatment of Prostatic CancerDrug Intelligence & Clinical Pharmacy, 1986
- Controlled delivery of an LHRH analogue from biodegradable injectable microspheresJournal of Controlled Release, 1985
- Controlled Release of a Luteinizing Hormone-Releasing Hormone Analogue from Poly(d,l-lactide—co-glycolide) MicrospheresJournal of Pharmaceutical Sciences, 1984
- A radioimmunoassay for a highly active luteinizing hormone-releasing hormone analogue and relation between the serum level of the analogue and that of gonadotropin.Endocrinologia Japonica, 1980
- Delay of Puberty and Inhibition of Reproductive Processes in the rat by a Gonadotropin-Releasing Hormone Agonist AnalogFertility and Sterility, 1976
- Resorption rate, route of elimination, and ultrastructure of the implant site of polylactic acid in the abdominal wall of the ratJournal of Biomedical Materials Research, 1973